DK0722317T3 - Liposomer med indhold af materialer på partikelform - Google Patents

Liposomer med indhold af materialer på partikelform

Info

Publication number
DK0722317T3
DK0722317T3 DK94928490T DK94928490T DK0722317T3 DK 0722317 T3 DK0722317 T3 DK 0722317T3 DK 94928490 T DK94928490 T DK 94928490T DK 94928490 T DK94928490 T DK 94928490T DK 0722317 T3 DK0722317 T3 DK 0722317T3
Authority
DK
Denmark
Prior art keywords
liposomes
water insoluble
particulate
mum
materials
Prior art date
Application number
DK94928490T
Other languages
Danish (da)
English (en)
Inventor
Gregory Gregoriadis
Sophia George Antimisiaris
Ihsan Gursel
Original Assignee
Secr Defence Brit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Secr Defence Brit filed Critical Secr Defence Brit
Application granted granted Critical
Publication of DK0722317T3 publication Critical patent/DK0722317T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/918—Immunological

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Detergent Compositions (AREA)
DK94928490T 1993-10-07 1994-10-07 Liposomer med indhold af materialer på partikelform DK0722317T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939320668A GB9320668D0 (en) 1993-10-07 1993-10-07 Liposomes containing particulare materials
PCT/GB1994/002191 WO1995009610A1 (en) 1993-10-07 1994-10-07 Liposomes containing particulate materials

Publications (1)

Publication Number Publication Date
DK0722317T3 true DK0722317T3 (da) 2002-05-21

Family

ID=10743157

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94928490T DK0722317T3 (da) 1993-10-07 1994-10-07 Liposomer med indhold af materialer på partikelform

Country Status (15)

Country Link
US (2) US6322809B1 (ru)
EP (1) EP0722317B1 (ru)
JP (1) JPH09503225A (ru)
KR (1) KR100357804B1 (ru)
CN (1) CN1108789C (ru)
AT (1) ATE209029T1 (ru)
AU (1) AU687893B2 (ru)
BR (1) BR9407769A (ru)
DE (1) DE69429186T2 (ru)
DK (1) DK0722317T3 (ru)
ES (1) ES2164714T3 (ru)
GB (2) GB9320668D0 (ru)
NZ (1) NZ274006A (ru)
RU (1) RU2145212C1 (ru)
WO (1) WO1995009610A1 (ru)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1289938B1 (it) * 1997-02-20 1998-10-19 Angelini Ricerche Spa Preparazione farmaceutica comprendente liposomi liofilizzati in cui e' incapsulato un principio attivo altamente insolubile in acqua e
AU735588B2 (en) 1997-09-18 2001-07-12 Pacira Pharmaceuticals, Inc. Sustained-release liposomal anesthetic compositions
ES2384094T3 (es) 1997-11-14 2012-06-29 Pacira Pharmaceuticals, Inc. Producción de liposomas multivesiculares
JP2002520120A (ja) 1998-07-17 2002-07-09 スカイファーマ インコーポレーテッド 封入物質の制御放出のための生分解性組成物
FR2802422B1 (fr) * 1999-12-21 2002-08-09 Capsulis Structures mixtes resultant de l'incorporation d'une macromolecule biologique, en particulier d'adn, dans une phase structuree d'amphiphiles et vesicules obtenues a partir de ces structures
WO2001056548A2 (en) * 2000-02-04 2001-08-09 Lipoxen Technologies Limited Liposomes composition produced by a dehydration-rehydration process
JP2004532252A (ja) * 2001-05-31 2004-10-21 スカイファーマ インコーポレーテッド リポソームおよびミクロスフェア中のナノ懸濁物のカプセル化
US20040005352A1 (en) * 2002-04-16 2004-01-08 Lopez Gabriel P. Biologically functionalized porous microspheres
SE0300795D0 (sv) 2003-03-24 2003-03-24 Isconova Ab Composition comprising iscom particles and live micro-organisms
EP1643972A4 (en) * 2003-06-27 2010-01-20 Smithkline Beecham Corp STABILIZED LIPOSOMAL TOPOTECAN COMPOSITION AND METHOD
EP1951762B1 (en) * 2005-10-03 2018-02-07 PINSKY, Mark A. Compositions and methods for improved skin care
FR2900576B1 (fr) * 2006-05-03 2008-09-19 Centre Nat Rech Scient Procede de concentration extemporanee et reversible de liposomes.
ES2708851T3 (es) * 2006-10-06 2019-04-11 Bionet Pharma Gmbh Un implante del núcleo pulposo espinal
US9456983B1 (en) 2006-12-08 2016-10-04 Advanced Cardiovascular Systems, Inc. Therapeutic composition with enhanced vessel targeting
US8372427B2 (en) * 2007-03-05 2013-02-12 Abbott Cardiovascular Systems Inc. Therapeutic composition with enhanced endothelium targeting
US9044385B2 (en) * 2007-05-16 2015-06-02 Abbott Cardiovascular Systems Inc. Therapeutic compositions for targeted vessel delivery
US20090047318A1 (en) 2007-08-16 2009-02-19 Abbott Cardiovascular Systems Inc. Nanoparticle-coated medical devices and formulations for treating vascular disease
US8709472B1 (en) 2007-11-13 2014-04-29 Abbott Cardiovascular Systems Inc. Bioactive agent-loaded heart-targeting nanoparticles
EP2222270B1 (en) 2007-12-26 2018-11-14 Mark A. Pinsky Collagen formulations for improved skin care
WO2010135714A2 (en) 2009-05-22 2010-11-25 The Methodist Hospital Research Institute Methods for modulating adipocyte expression using microrna compositions
WO2011123525A1 (en) * 2010-04-01 2011-10-06 The Regents Of The University Of California Forming an artificial cell with controlled membrane composition, asymmetry and contents
EP2576813A1 (en) * 2010-05-28 2013-04-10 Diagon Kft. Procedure for biphasic preparation of liposomes and application thereof in manufacturing diagnostic reagents
CN102240531B (zh) * 2011-03-21 2013-07-10 徐涵 一种植物细胞微球及其应用
EP2682106A1 (en) * 2012-07-03 2014-01-08 Phares Pharmaceutical Research N.V. Method of solubilizing biologically active compounds
JP6608422B2 (ja) * 2014-03-25 2019-11-20 ザ ガバメント オブ ザ ユナイテッド ステイツ，アズ リプリゼンティッド バイ ザ セクレタリー オブ ジ アーミー モノホスホリルリピッドａ（ｍｐｌａ）含有リポソーム組成物およびサポニンを含む非毒性アジュバント製剤
RU2589822C2 (ru) * 2014-12-02 2016-07-10 Федеральное государственное бюджетное учреждение науки Институт ядерной физики им. Г.И. Будкера Сибирского отделения РАН (ИЯФ СО РАН) Способ доставки борсодержащих препаратов для бор-нейтронозахватной терапии
JP6316182B2 (ja) 2014-12-19 2018-04-25 富士フイルム株式会社 リポソームの製造方法及びリポソーム製造装置
US20170049701A1 (en) * 2015-08-05 2017-02-23 Steven M. Kushner Clustoidal multilamellar soy lecithin phospholipid structures for transdermal, transmucosal, or oral delivery, improved intestinal absorption, and improved bioavailability of nutrients
KR101687735B1 (ko) * 2015-09-18 2016-12-19 서울대학교 산학협력단 신규의 동결건조보조제 및 새로운 인지질 용해용 혼합용매를 이용한 리포좀 동결분체의 제조방법
EP3371349A4 (en) 2015-11-02 2018-09-12 Bioatla, LLC Conditionally active polypeptides
CN105483076B (zh) * 2015-12-23 2019-01-25 中国科学院生物物理研究所 一种脂肪体的制备方法及其应用
WO2018094253A1 (en) 2016-11-18 2018-05-24 Pacira Pharmaceuticals, Inc. Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same
EP3415140A1 (en) * 2017-06-16 2018-12-19 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. A method for preparing a functional synthetic cell in form of a giant unilamellar vesicle
US10849924B2 (en) 2017-09-26 2020-12-01 New York Medical College Compositions and methods for restoring endothelial glycocalyx
JP7157999B2 (ja) * 2018-05-07 2022-10-21 国立研究開発法人産業技術総合研究所 微生物を封入したベシクルを用いた微生物の培養方法
IL301354A (en) 2020-09-16 2023-05-01 Aviceda Therapeutics Inc Therapeutic agents decorated with sialic acid ligand
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
WO2023129737A1 (en) 2021-12-31 2023-07-06 Aviceda Therapeutics, Inc. Glycomimetic ligands

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201767A (en) * 1978-11-08 1980-05-06 Merck & Co., Inc. Viral liposome particle
HU184141B (en) 1979-12-27 1984-07-30 Human Oltoanyagtermelo Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
EP0088046B1 (de) * 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipide in wässriger Phase
US4532089A (en) * 1984-01-14 1985-07-30 Northwestern University Method of preparing giant size liposomes
US4880635B1 (en) 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
DE3582905D1 (de) 1984-08-10 1991-06-27 Syntex Inc Stabile liposome mit wasserloeslichen arzneimitteln.
JPS6150912A (ja) 1984-08-16 1986-03-13 Shionogi & Co Ltd リポソ−ム製剤の製造法
US4814270A (en) 1984-09-13 1989-03-21 Becton Dickinson And Company Production of loaded vesicles
JPS6176414A (ja) 1984-09-21 1986-04-18 Shionogi & Co Ltd リポソーム製剤の製法
GB8424115D0 (en) 1984-09-24 1984-10-31 Mead Corp Article tray
US5049390A (en) * 1987-09-02 1991-09-17 Allergy Immuno Technologies, Inc. Liposome containing immunotherapy agents for treating IgE mediated allergies
US5422120A (en) * 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
US5157207A (en) * 1990-02-06 1992-10-20 Crop Genetics International Modified plant containing a bacterial insculant
GB9018690D0 (en) * 1990-08-24 1990-10-10 Wellcome Found Vaccines
DE4136553A1 (de) * 1991-11-06 1993-05-13 Biotechnolog Forschung Gmbh Impfstoff gegen schleimhauterreger und herstellungsverfahren
DK0684812T3 (da) 1993-02-12 1998-09-21 Mayo Foundation Kondenseret-fase mikropartikel-præparat og fremgangsmåde

Also Published As

Publication number Publication date
JPH09503225A (ja) 1997-03-31
ES2164714T3 (es) 2002-03-01
EP0722317B1 (en) 2001-11-21
US6451338B1 (en) 2002-09-17
GB9320668D0 (en) 1993-11-24
GB2297907A (en) 1996-08-21
DE69429186T2 (de) 2002-07-11
DE69429186D1 (de) 2002-01-03
AU687893B2 (en) 1998-03-05
NZ274006A (en) 1997-02-24
CN1108789C (zh) 2003-05-21
US6322809B1 (en) 2001-11-27
GB9607359D0 (en) 1996-07-03
US20020041895A1 (en) 2002-04-11
ATE209029T1 (de) 2001-12-15
GB2297907B (en) 1997-12-10
BR9407769A (pt) 1997-03-18
KR100357804B1 (ko) 2004-06-14
RU2145212C1 (ru) 2000-02-10
WO1995009610A1 (en) 1995-04-13
CN1200668A (zh) 1998-12-02
AU7790794A (en) 1995-05-01
EP0722317A1 (en) 1996-07-24

Similar Documents

Publication Publication Date Title
DK0722317T3 (da) Liposomer med indhold af materialer på partikelform
US5044091B1 (en) Method of preparing a freeze-dried formulation of a drug
BR8705040A (pt) Composicao inseticida ativa,espumavel,soluvel em agua e processo para sua producao
ES2088160T3 (es) Formulacion y proceso quimicos.
BR8000192A (pt) Processo para o melhoramento da solubilidade de substancias ativas de atividade biologica,compostos com solubilidade melhorada e processo para sua preparacao
DE68904326D1 (de) Physiologisch aktive substanzen enthaltende mikrosphaeren des polymilchsaeuretyps sowie verfahren zu deren herstellung.
ES2029269T3 (es) Un metodo de fabricacion de una formulacion de liberacion lenta.
DE69000881D1 (de) 2-propylvaleriansaeure enthaltende arzneizubereitung mit verzoegerter wirkstofffreigabe.
RU92016471A (ru) Твердая непористая микросфера, способ ее получения и применение в фармакологическом препарате
FR2601259B1 (fr) Nouvelles compositions tensio-actives a base d'esters phosphoriques leur procede de preparation et leur application a la formulation de matieres actives.
ES2065906T3 (es) Produccion de proteinas en formas activas.
DE69904954D1 (de) Verfahren zur herstellung neuer fenofibrathaltiger arzneiformulierungen, dadurch hergestellte arzneiformulierungen und ihre verwendung
ATE87467T1 (de) Pharmazeutische zubereitung.
MX170706B (es) Procedimiento para la preparacion de (-) -n"ciano-n-3- piridil -n'- 1, 2, 2-trimetilpropilguanidina
CA2173601A1 (en) Liposomes containing particulate materials
FR2600671B1 (fr) Procede de conservation cryogenique de substances et matieres organiques, notamment de cellules
DE3772655D1 (de) Herstellung von methakrylsaeure und katalysatoren dazu.
BR8001868A (pt) Processo para melhorar a solubilidade de substancias biologicamente ativas, compostos e processo para a preparacao de compostos
DE3881812D1 (de) Physiologisch aktive substanzen, probestin und prostatin und deren herstellung.
DE69017870D1 (de) Pharmazeutische Zubereitungen, die 3-Oxygermylpropionsäurepolymere enthalten zur Hemmung von Zelldegeneration.
TH2453A (th) สูตรผสมยาฆ่าพยาธิชนิดที่ละลายน้ำได้น้อยและกรรมวิธีสำหรับการเตรียมสูตรผสมต่าง ๆ นี้
RU2002129262A (ru) Способ получения липосомальных препаратов
RU97105225A (ru) Способ стимуляции иммунного ответа in vitro
TH2453EX (th) สูตรผสมยาฆ่าพยาธิชนิดที่ละลายน้ำได้น้อยและกรรมวิธีสำหรับการเตรียมสูตรผสมต่าง ๆ นี้
ATE96336T1 (de) Anordnung zur selbstverabreichung physiologisch aktiver substanzen unter vorbeugung einer ueberdosierung.